A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: pegfilgrastim|DRUG: cyclophosphamide|DRUG: methotrexate|DRUG: 5-fluorouracil
Sponsor: Amgen